Ascend Capital’s Alto Ingredients ALTO Stock Holding History

Ascend Capital’s Portfolio ALTO Stock Details ALTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-572,021	Closed	-$5.91M	–	165
2014 Q4	$5.91M	Sell	572,021 -48,407	-8%	-$591K	0.23%	114
2014 Q3	$8.66M	Buy	620,428 +270,378	+77%	+$5.09M	0.26%	116
2014 Q2	$5.35M	Buy	+350,050	New	+$4.85M	0.18%	128

Other funds holding ALTO

Dalton Investments Las Vegas, Nevada $111M AUM 7.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

CIG

Candlewood Investment Group Rye, New York $10.1M AUM 30% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TCM

Trafelet Capital Management New York $11.8M AUM 13.32% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ascend Capital's ALTO Position: Q1 2015 in Review

Ascend Capital sold out of Alto Ingredients (ALTO) in Q1 2015, closing a stake of 572,021 shares — an estimated $5.91M sold.

Ascend Capital first reported a position in ALTO in Q2 2014 and held it in 3 quarters. The position peaked at $8.66M in Q3 2014. 127 funds tracked by Wall St. Rank hold ALTO as of Q1 2015.

Ascend Capital reported no remaining Alto Ingredients position as of Q1 2015 after selling out during the quarter.
Ascend Capital sold 572,021 Alto Ingredients shares in Q1 2015, an estimated $5.91M.
Ascend Capital first reported a position in Alto Ingredients in Q2 2014 and held it in 3 quarters.
Ascend Capital's Alto Ingredients position peaked at $8.66M in Q3 2014.
127 funds tracked by Wall St. Rank held Alto Ingredients as of Q1 2015.

Based on Ascend Capital's 13F filing for Q1 2015, filed 14 May 2015.